Trials / Conditions / Human Immunodeficiency Virus (HIV) Infection

Human Immunodeficiency Virus (HIV) Infection

16 registered clinical trials studyying Human Immunodeficiency Virus (HIV) Infection — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India NCT07209917	University of California, Irvine	N/A
Not Yet Recruiting	Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV NCT07039682	Universitas Sebelas Maret	N/A
Recruiting	Strategies to AchieVe Viral Suppression for Youth With HIV NCT06886971	Johns Hopkins University	N/A
Terminated	Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressiv NCT06430905	Hookipa Biotech GmbH	Phase 1
Completed	Same-day Versus Rapid ART Initiation in HIV-positive Individuals Presenting With Symptoms of Tuberculosis NCT05452616	University Hospital, Basel, Switzerland	N/A
Recruiting	Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg NCT04375800	Merck Sharp & Dohme LLC	Phase 2
Completed	Single-Dose Islatravir in Moderate Hepatic Impairment (MK-8591-030) NCT04515641	Merck Sharp & Dohme LLC	Phase 1
Completed	Pharmacokinetics of Islatravir in Participants With Severe Renal Impairment (MK-8591-026) NCT04303156	Merck Sharp & Dohme LLC	Phase 1
Completed	Safety, Tolerability, and Pharmacokinetics of Raltegravir (MK-0518) in Healthy Japanese Male Participants (MK- NCT03667547	Merck Sharp & Dohme LLC	Phase 4
Completed	Interventions to Improve HIV Antiretroviral Therapy Adherence NCT03618511	University of Michigan	N/A
Terminated	Soy Modulation of Immune Activation, LDL- Levels, and Lowering Inflammation by Pretzel Isoflavone Dietary Inte NCT02818283	Ohio State University	N/A
Completed	Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-04 NCT02715700	Merck Sharp & Dohme LLC	Phase 1
Completed	A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination W NCT01422330	Janssen R&D Ireland	Phase 4
Completed	Folinic Acid and Vascular Reactivity in HIV NCT01768182	Hospital de Clinicas de Porto Alegre	N/A
Completed	Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male NCT00821535	ViiV Healthcare	Phase 1
Completed	Pharmacokinetics, Safety And Toleration Of Maraviroc Administered To Subjects With Various Degrees Of Renal Im NCT00717067	ViiV Healthcare	Phase 4